LITE STRATEGY INC (LITS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:LITS • US55279B3015

1.11 USD
-0.03 (-2.63%)
Last: Feb 3, 2026, 12:43 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LITS. LITS was compared to 524 industry peers in the Biotechnology industry. While LITS has a great health rating, there are worries on its profitability. LITS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • LITS had negative earnings in the past year.
  • In the past year LITS has reported a negative cash flow from operations.
  • LITS had negative earnings in 4 of the past 5 years.
  • LITS had a negative operating cash flow in each of the past 5 years.
LITS Yearly Net Income VS EBIT VS OCF VS FCFLITS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • LITS's Return On Assets of -87.20% is on the low side compared to the rest of the industry. LITS is outperformed by 71.18% of its industry peers.
  • LITS has a Return On Equity of -94.18%. This is comparable to the rest of the industry: LITS outperforms 47.90% of its industry peers.
Industry RankSector Rank
ROA -87.2%
ROE -94.18%
ROIC N/A
ROA(3y)-23.53%
ROA(5y)-24.99%
ROE(3y)-56.59%
ROE(5y)-71.43%
ROIC(3y)N/A
ROIC(5y)N/A
LITS Yearly ROA, ROE, ROICLITS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • LITS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LITS Yearly Profit, Operating, Gross MarginsLITS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

7

2. Health

2.1 Basic Checks

  • LITS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LITS has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LITS has been increased compared to 5 years ago.
  • LITS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LITS Yearly Shares OutstandingLITS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
LITS Yearly Total Debt VS Total AssetsLITS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -14.40, we must say that LITS is in the distress zone and has some risk of bankruptcy.
  • LITS has a Altman-Z score of -14.40. This is in the lower half of the industry: LITS underperforms 79.01% of its industry peers.
  • LITS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.4
ROIC/WACCN/A
WACC8.9%
LITS Yearly LT Debt VS Equity VS FCFLITS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • A Current Ratio of 13.50 indicates that LITS has no problem at all paying its short term obligations.
  • LITS's Current ratio of 13.50 is amongst the best of the industry. LITS outperforms 89.69% of its industry peers.
  • A Quick Ratio of 13.50 indicates that LITS has no problem at all paying its short term obligations.
  • The Quick ratio of LITS (13.50) is better than 89.89% of its industry peers.
Industry RankSector Rank
Current Ratio 13.5
Quick Ratio 13.5
LITS Yearly Current Assets VS Current LiabilitesLITS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

1

3. Growth

3.1 Past

  • LITS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -189.72%.
  • The Revenue for LITS has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-189.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.4%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • LITS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.35% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y40.92%
EPS Next 2Y32.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LITS Yearly Revenue VS EstimatesLITS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 20M 40M 60M
LITS Yearly EPS VS EstimatesLITS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15 -20

1

4. Valuation

4.1 Price/Earnings Ratio

  • LITS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year LITS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LITS Price Earnings VS Forward Price EarningsLITS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LITS Per share dataLITS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LITS's earnings are expected to grow with 32.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.35%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • LITS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

LITE STRATEGY INC

NASDAQ:LITS (2/3/2026, 12:43:54 PM)

1.11

-0.03 (-2.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)02-10
Inst Owners26.78%
Inst Owner ChangeN/A
Ins Owners10.79%
Ins Owner Change-15.86%
Market Cap40.84M
Revenue(TTM)N/A
Net Income(TTM)-15.95M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.41
P/tB 2.41
EV/EBITDA N/A
EPS(TTM)-2.39
EYN/A
EPS(NY)-3.78
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0
BVpS0.46
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.2%
ROE -94.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.53%
ROA(5y)-24.99%
ROE(3y)-56.59%
ROE(5y)-71.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.5
Quick Ratio 13.5
Altman-Z -14.4
F-Score2
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)4.03%
Cap/Depr(5y)80.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-189.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.4%
EPS Next Y40.92%
EPS Next 2Y32.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-168.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.7%
OCF growth 3YN/A
OCF growth 5YN/A

LITE STRATEGY INC / LITS FAQ

What is the ChartMill fundamental rating of LITE STRATEGY INC (LITS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LITS.


Can you provide the valuation status for LITE STRATEGY INC?

ChartMill assigns a valuation rating of 1 / 10 to LITE STRATEGY INC (LITS). This can be considered as Overvalued.


How profitable is LITE STRATEGY INC (LITS) stock?

LITE STRATEGY INC (LITS) has a profitability rating of 0 / 10.


What is the earnings growth outlook for LITE STRATEGY INC?

The Earnings per Share (EPS) of LITE STRATEGY INC (LITS) is expected to grow by 40.92% in the next year.


How sustainable is the dividend of LITE STRATEGY INC (LITS) stock?

The dividend rating of LITE STRATEGY INC (LITS) is 0 / 10 and the dividend payout ratio is 0%.